Loading...
Please wait, while we are loading the content...
Similar Documents
Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
| Content Provider | MDPI |
|---|---|
| Author | Han, Liang |
| Copyright Year | 2021 |
| Description | The blood–brain barrier (BBB) precisely controls brain microenvironment and neural activity by regulating substance transport into and out of the brain. However, it severely hinders drug entry into the brain, and the efficiency of various systemic therapies against brain diseases. Modulation of the BBB via opening tight junctions, inhibiting active efflux and/or enhancing transcytosis, possesses the potential to increase BBB permeability and improve intracranial drug concentrations and systemic therapeutic efficiency. Various strategies of BBB modulation have been reported and investigated preclinically and/or clinically. This review describes conventional and emerging BBB modulation strategies and related mechanisms, and safety issues according to BBB structures and functions, to try to give more promising directions for designing more reasonable preclinical and clinical studies. |
| Starting Page | 2024 |
| e-ISSN | 19994923 |
| DOI | 10.3390/pharmaceutics13122024 |
| Journal | Pharmaceutics |
| Issue Number | 12 |
| Volume Number | 13 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-11-27 |
| Access Restriction | Open |
| Subject Keyword | Pharmaceutics Neurosciences Blood–brain Barrier Modulation Tight Junction Active Efflux Transcytosis Drug Delivery |
| Content Type | Text |
| Resource Type | Article |